Estrogen levels by weight in premenopausal breast cancer patients
Part of Hormones & metabolism clinical trials.
This study looks at how body weight affects estrogen levels in premenopausal women with breast cancer who are receiving hormone therapy. It aims to see if current treatments are effective across different body sizes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with hormone receptor-positive breast cancer (a type that grows in response to hormones).
- You are premenopausal and have started ovarian suppression (treatment to stop your ovaries from making hormones).
- You have been taking an aromatase inhibitor (like anastrozole, letrozole, or exemestane) and a GnRH analog (like goserelin or leuprolide) for at least 3 months.
- You do not have metastatic breast cancer (cancer that has spread to other parts of the body).
- You are not taking medications that might affect estrogen levels, such as high-dose steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a weight-loss medication can affect breast cancer tumors before surgery. It is for postmenopausal women with early-stage, hormone-positive breast cancer who are overweight or obese.
This study looks at how hormone therapy for breast cancer affects your body's metabolism, such as blood sugar and cholesterol. It aims to understand these changes early so doctors can better support your health during treatment.
This trial tests if giving hormone-blocking pills before surgery can help guide which treatments you need after surgery. It is for premenopausal women with early-stage, hormone-sensitive breast cancer.
This study looks at how a hormone called AMH changes during breast cancer treatment to help predict how well your ovaries are working as you approach menopause. It may help doctors better understand fertility and ovarian health for women in your situation.
This study looks at how temporarily stopping ovarian function affects weight, body fat, and blood vessel health in premenopausal women. If you qualify, you might help researchers understand the risks and benefits of short-term estrogen suppression.
This study looks at how well women stick to their hormone therapy plan after breast cancer surgery. The treatment includes ovarian suppression (to lower estrogen) plus endocrine therapy, and the goal is to see how well it works in real life.
Hear when a new Hormone-receptor-positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.